[email protected]
On Twitter @mitchelzoler
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Converge Coverage
Atrial fibrillation blunts beta-blockers for HFrEF
AT HEART FAILURE 2017
Related Articles
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
June 11, 2017
Clinical question: Are there alternatives to statins for primary prevention? Background: Statins that lower low-density lipoprotein (LDL) cholesterol are major therapeutics in reducing both primary...
Beta-Blocker Interruption or Continuation after Myocardial Infarction
June 11, 2017
Clinical question: Is the interrupted use of a beta-blocker non-inferior to its continued use in patients with a history of myocardial infarction (MI)? Background: Patients with MI are often started...
Can Salt Stir the Pot? Sodium’s Effect on Heart Failure Clinical Outcomes
June 11, 2017
Clinical question: Is there an association between baseline dietary sodium intake and clinical outcomes in heart failure? Background: Dietary sodium restriction is common advice for patients with...
Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients with Cirrhosis and AF
June 11, 2017
Clinical question: What is the effectiveness and safety of apixaban, rivaroxaban, and warfarin in patients with cirrhosis and atrial fibrillation? Background: The use of direct oral anticoagulants...